(Q56944772)

English

Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials ∗ ∗A complete list of the principal investigators and study coordinators of the EPILOG (Evaluation in PTCA to Improve Long-term Outcome with abciximab GP

scientific article published on 01 August 2000

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969673%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials. Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibition in STENTing (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969673%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969673%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

10

object named as

R M Califf

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969673%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

A Michael Lincoff

1

object named as

A M Lincoff

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969673%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

ORCID Public Data File 2021

author name string

L A LeNarz

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969673%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

G J Despotis

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969673%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

P K Smith

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969673%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J E Booth

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969673%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

R E Raymond

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969673%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

S K Sapp

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969673%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

C F Cabot

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969673%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J E Tcheng

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969673%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M B Effron

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969673%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

0 references

publication date

1 August 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969673%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

The Annals of Thoracic Surgery

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969673%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

70

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969673%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969673%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

516-526

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969673%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty.

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901343-6

7 January 2021

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901343-6

7 January 2021

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901343-6

7 January 2021

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901343-6

7 January 2021

Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901343-6

7 January 2021

Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901343-6

7 January 2021

Abciximab and excessive bleeding in patients undergoing emergency cardiac operations

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901343-6

7 January 2021

Effects of profound platelet inhibition with c7E3 before coronary angioplasty on complications of coronary bypass surgery. EPIC Investigators. Evaluation Prevention of Ischemic Complications

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901343-6

7 January 2021

Bleeding during thrombolytic therapy for acute myocardial infarction: mechanisms and management

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901343-6

7 January 2021

Practice strategies for elective red blood cell transfusion. American College of Physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901343-6

7 January 2021

Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901343-6

7 January 2021

Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901343-6

7 January 2021

Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901343-6

7 January 2021

Failed elective percutaneous transluminal coronary angioplasty requiring coronary artery bypass surgery. In-hospital and late clinical outcome at 5 years

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901343-6

7 January 2021

Disrupted coronary artery caused by angioplasty: supportive and surgical considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901343-6

7 January 2021

Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: Implications for inhibition of the internal pool of GPIIb/IIIa receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901343-6

7 January 2021

Emergency coronary bypass grafting for failed percutaneous coronary artery stenting: increased costs and platelet transfusion requirements after the use of abciximab

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901343-6

7 January 2021

Surgical implications of platelet glycoprotein IIb-IIIa inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901343-6

7 January 2021

Determinants of red cell, platelet, plasma, and cryoprecipitate transfusions during coronary artery bypass graft surgery: the Collaborative Hospital Transfusion Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901343-6

7 January 2021

Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention. EPIC Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901343-6

7 January 2021

Intracardiac thrombus: a risk of incomplete anticoagulation for cardiac operations

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901343-6

7 January 2021

Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (the EPIC trial). Evaluation of c7E3 Fab in the Prevention of Ischemic Complicatio

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901343-6

7 January 2021

Integrilin prevents prolonged bleeding times after cardiopulmonary bypass.

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901343-6

7 January 2021

Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901343-6

7 January 2021

Identifiers

10.1016/S0003-4975(00)01343-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969673%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10969673%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56944772&oldid=1757010643"